50 related articles for article (PubMed ID: 12710196)
1. Identifying inhibitors of ATM and ATR kinase activities.
Sarkaria JN
Methods Mol Med; 2003; 85():49-56. PubMed ID: 12710196
[No Abstract] [Full Text] [Related]
2. Ataxia telangiectasia-related protein is involved in the phosphorylation of BRCA1 following deoxyribonucleic acid damage.
Chen J
Cancer Res; 2000 Sep; 60(18):5037-9. PubMed ID: 11016625
[TBL] [Abstract][Full Text] [Related]
3. The role of ATM and ATR in DNA damage-induced cell cycle control.
Goodarzi AA; Block WD; Lees-Miller SP
Prog Cell Cycle Res; 2003; 5():393-411. PubMed ID: 14593734
[TBL] [Abstract][Full Text] [Related]
4. DNA-PK, ATM and MDR proteins inhibitors in overcoming fludarabine resistance in CLL cells.
Svirnovski AI; Serhiyenka TF; Kustanovich AM; Khlebko PV; Fedosenko VV; Taras IB; Bakun AV
Exp Oncol; 2010 Dec; 32(4):258-62. PubMed ID: 21270755
[TBL] [Abstract][Full Text] [Related]
5. Targeting polo-like kinase: learning too little too late?
Olmos D; Swanton C; de Bono J
J Clin Oncol; 2008 Dec; 26(34):5497-9. PubMed ID: 18955441
[No Abstract] [Full Text] [Related]
6. Sodium salicylate acts through direct inhibition of phosphoinositide 3-kinase-like kinases to modulate topoisomerase-mediated DNA damage responses.
Fan JR; Huang TH; Wen CY; Shen TL; Li TK
Eur J Pharmacol; 2010 Jul; 638(1-3):13-20. PubMed ID: 20406630
[TBL] [Abstract][Full Text] [Related]
7. Differential involvement of phosphatidylinositol 3-kinase-related protein kinases in hyperphosphorylation of replication protein A2 in response to replication-mediated DNA double-strand breaks.
Sakasai R; Shinohe K; Ichijima Y; Okita N; Shibata A; Asahina K; Teraoka H
Genes Cells; 2006 Mar; 11(3):237-46. PubMed ID: 16483312
[TBL] [Abstract][Full Text] [Related]
8. Caspase-mediated cleavage of ATM during cisplatin-induced tubular cell apoptosis: inactivation of its kinase activity toward p53.
Wang J; Pabla N; Wang CY; Wang W; Schoenlein PV; Dong Z
Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1300-7. PubMed ID: 16849690
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Atm and/or Atr disrupts gene silencing on the inactive X chromosome.
Ouyang Y; Salstrom J; Diaz-Perez S; Nahas S; Matsuno Y; Dawson D; Teitell MA; Horvath S; Riggs AD; Gatti RA; Marahrens Y
Biochem Biophys Res Commun; 2005 Nov; 337(3):875-80. PubMed ID: 16213462
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle-dependent DNA damage signaling induced by ICRF-193 involves ATM, ATR, CHK2, and BRCA1.
Park I; Avraham HK
Exp Cell Res; 2006 Jul; 312(11):1996-2008. PubMed ID: 16630610
[TBL] [Abstract][Full Text] [Related]
11. Etoposide and adriamycin but not genistein can activate the checkpoint kinase Chk2 independently of ATM/ATR.
Théard D; Coisy M; Ducommun B; Concannon P; Darbon JM
Biochem Biophys Res Commun; 2001 Dec; 289(5):1199-204. PubMed ID: 11741320
[TBL] [Abstract][Full Text] [Related]
12. Polo and Aurora kinases: lessons derived from chemical biology.
Taylor S; Peters JM
Curr Opin Cell Biol; 2008 Feb; 20(1):77-84. PubMed ID: 18249108
[TBL] [Abstract][Full Text] [Related]
13. Extracellular signal-related kinase positively regulates ataxia telangiectasia mutated, homologous recombination repair, and the DNA damage response.
Golding SE; Rosenberg E; Neill S; Dent P; Povirk LF; Valerie K
Cancer Res; 2007 Feb; 67(3):1046-53. PubMed ID: 17283137
[TBL] [Abstract][Full Text] [Related]
14. Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1.
Denchi EL; de Lange T
Nature; 2007 Aug; 448(7157):1068-71. PubMed ID: 17687332
[TBL] [Abstract][Full Text] [Related]
15. Telomerase inhibition potentiates the effects of genotoxic agents in breast and colorectal cancer cells in a cell cycle-specific manner.
Tamakawa RA; Fleisig HB; Wong JM
Cancer Res; 2010 Nov; 70(21):8684-94. PubMed ID: 20837664
[TBL] [Abstract][Full Text] [Related]
16. Cleavage of Cdc6 by caspase-3 promotes ATM/ATR kinase-mediated apoptosis of HeLa cells.
Yim H; Hwang IS; Choi JS; Chun KH; Jin YH; Ham YM; Lee KY; Lee SK
J Cell Biol; 2006 Jul; 174(1):77-88. PubMed ID: 16801388
[TBL] [Abstract][Full Text] [Related]
17. Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinase.
Hollick JJ; Rigoreau LJ; Cano-Soumillac C; Cockcroft X; Curtin NJ; Frigerio M; Golding BT; Guiard S; Hardcastle IR; Hickson I; Hummersone MG; Menear KA; Martin NM; Matthews I; Newell DR; Ord R; Richardson CJ; Smith GC; Griffin RJ
J Med Chem; 2007 Apr; 50(8):1958-72. PubMed ID: 17371003
[TBL] [Abstract][Full Text] [Related]
18. PLK1 inhibitors: setting the mitotic death trap.
Plyte S; Musacchio A
Curr Biol; 2007 Apr; 17(8):R280-3. PubMed ID: 17437704
[TBL] [Abstract][Full Text] [Related]
19. Chronicles in drug discovery.
Khurdayan V; Bozzo J; Sorbera L
Drug News Perspect; 2005 Jun; 18(5):332-6. PubMed ID: 16193105
[TBL] [Abstract][Full Text] [Related]
20. The instability of polyhydroxylated aromatic protein tyrosine kinase inhibitors in the presence of manganese.
Ramdas L; Budde RJ
Cancer Biochem Biophys; 1998 Nov; 16(4):375-85. PubMed ID: 9925284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
